Actualités Medicalcv (MM) - MDCV | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MedicalCV Elects Larry Haimovitch and Robert Paulson to Board of Directors

MINNEAPOLIS, Aug. 8 /PRNewswire-FirstCall/ -- MedicalCV, Inc. (OTC:MDCV) (BULLETIN BOARD: MDCV) , http://www.medcvinc.com/, a cardiovascular...

MedicalCV Establishes Scientific Advisory Board Comprised of Distinguished Cardiac Surgeons and Scientific Experts

MedicalCV Establishes Scientific Advisory Board Comprised of Distinguished Cardiac Surgeons and Scientific Experts Dr. Patrick M. McCarthy, Chief...

MedicalCV to Present at Medtech Insight's 'Investment in Innovation' Conference

MedicalCV to Present at Medtech Insight's 'Investment in Innovation' Conference Company Scheduled to Present in San Francisco on Tuesday, June 14...

MedicalCV Announces Addition of Industry Experts to ATRILAZE(TM) Research & Development Team

MedicalCV Announces Addition of Industry Experts to ATRILAZE(TM) Research & Development Team Company Takes Proactive Steps to Enhance Strategic...

MedicalCV Announces Information to Be Available Through S&P Market Access Program

MedicalCV Announces Information to Be Available Through S&P Market Access Program MINNEAPOLIS, May 2 /PRNewswire-FirstCall/ -- MedicalCV, Inc...

MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(TM) System for Cardiac Tissue Ablation

MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(TM) System for Cardiac Tissue Ablation Two Months After...

MedicalCV Announces Sales of the Omnicarbon(R) Mechanical Heart Valve to Cease on April 30, 2005

MedicalCV Announces Sales of the Omnicarbon(R) Mechanical Heart Valve to Cease on April 30, 2005 Company Gaining Market Recognition of Its...

MedicalCV Announces Industry Recognition Excellence in Technology Award from Frost and Sullivan

MedicalCV Announces Industry Recognition Excellence in Technology Award from Frost and Sullivan Company Receives Industry Recognition in the Field...

MedicalCV, Inc. Signs and Closes $13.6 Million Private Financing and Converts $4.4 Million of Debt Into Equity

MedicalCV, Inc. Signs and Closes $13.6 Million Private Financing and Converts $4.4 Million of Debt Into Equity MINNEAPOLIS, April 4...

MedicalCV Announces Retention of ROI Group Associates, Inc. as Its Investor Relations Firm

MedicalCV Announces Retention of ROI Group Associates, Inc. as Its Investor Relations Firm MINNEAPOLIS, Jan. 31 /PRNewswire-FirstCall/...

MedicalCV Announces Completion of First U.S. Clinical Case Using AtriLaze(TM) Surgical Ablation System in Open-Heart Surgery

MedicalCV Announces Completion of First U.S. Clinical Case Using AtriLaze(TM) Surgical Ablation System in Open-Heart Surgery The Laser System...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medicalcv (MM) (MDCV)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MDCV Actualités

MedicalCV Elects Larry Haimovitch and Robert Paulson to Board of Directors

MedicalCV Establishes Scientific Advisory Board Comprised of Distinguished Cardiac Surgeons and Scientific Experts

MedicalCV to Present at Medtech Insight's 'Investment in Innovation' Conference

MedicalCV Announces Addition of Industry Experts to ATRILAZE(TM) Research & Development Team

MedicalCV Announces Information to Be Available Through S&P Market Access Program

MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(TM) System for Cardiac Tissue Ablation

MedicalCV Announces Sales of the Omnicarbon(R) Mechanical Heart Valve to Cease on April 30, 2005

MedicalCV Announces Industry Recognition Excellence in Technology Award from Frost and Sullivan

MedicalCV, Inc. Signs and Closes $13.6 Million Private Financing and Converts $4.4 Million of Debt Into Equity

MedicalCV Announces Retention of ROI Group Associates, Inc. as Its Investor Relations Firm

MedicalCV Announces Completion of First U.S. Clinical Case Using AtriLaze(TM) Surgical Ablation System in Open-Heart Surgery

MedicalCV Announces Continued Milestone Achievement

MedicalCV Announces 510(k) Clearance of Its ATRILAZE(TM) Surgical Ablation System for Use in Surgery

MedicalCV, Inc. Class A Warrants Expire And Public Units Automatically Become Shares Of Common Stock

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medicalcv (MM) (MDCV) Actualités

Medicalcv (MM) (MDCV)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MDCV Actualités

MedicalCV Elects Larry Haimovitch and Robert Paulson to Board of Directors

MedicalCV Establishes Scientific Advisory Board Comprised of Distinguished Cardiac Surgeons and Scientific Experts

MedicalCV to Present at Medtech Insight's 'Investment in Innovation' Conference

MedicalCV Announces Addition of Industry Experts to ATRILAZE(TM) Research & Development Team

MedicalCV Announces Information to Be Available Through S&P Market Access Program

MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(TM) System for Cardiac Tissue Ablation

MedicalCV Announces Sales of the Omnicarbon(R) Mechanical Heart Valve to Cease on April 30, 2005

MedicalCV Announces Industry Recognition Excellence in Technology Award from Frost and Sullivan

MedicalCV, Inc. Signs and Closes $13.6 Million Private Financing and Converts $4.4 Million of Debt Into Equity

MedicalCV Announces Retention of ROI Group Associates, Inc. as Its Investor Relations Firm

MedicalCV Announces Completion of First U.S. Clinical Case Using AtriLaze(TM) Surgical Ablation System in Open-Heart Surgery

MedicalCV Announces Continued Milestone Achievement

MedicalCV Announces 510(k) Clearance of Its ATRILAZE(TM) Surgical Ablation System for Use in Surgery

MedicalCV, Inc. Class A Warrants Expire And Public Units Automatically Become Shares Of Common Stock

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application